Laura Agee
Nurse Practitioner · Kansas City, KSNPI 1700394699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 25.5% of the total. Reporting peaked in 2022 at $1,212 and has fallen 97.2% since, to $34 in 2025. Among nurse practitioner clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$737
- AstraZeneca$291
- Novo Nordisk$243
- Lilly USA, LLC$200
- Amgen$188
- Boehringer Ingelheim$153
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,886100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $737 |
| AstraZeneca(2 entities) | 18 | $291 |
| Novo Nordisk | 15 | $243 |
| Lilly USA, LLC | 14 | $200 |
| Amgen | 12 | $188 |
| Boehringer Ingelheim | 10 | $153 |
| Pfizer | 8 | $120 |
| Merck | 5 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $80 |
| Bayer | 5 | $75 |
| GSK | 4 | $67 |
| Amarin Pharma, Inc. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Cranial Technologies, Inc | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $48 |
| Abbott | 2 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $40 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Cvrx, Inc. | 1 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Covis Pharma GmbH | 2 | $29 |
| Johnson & Johnson | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,886 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Kansas City
- Dana MillerKansas City$13K
- Jason OralloKansas City$10K
- Ashlee OrndorffKansas City$7K
- Paul WohletzKansas City$6K
- Emily OstranderKansas City$5K
- Gary GrafTopeka$726K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.